|
|
||||||||
Eur J Cardiothorac Surg 1999;15:383-388
© 1999 Elsevier Science NL
a Department of Thoracic and Cardiovascular Surgery, Hannover Medical School, Hannover, Germany
b Department of Cardiology, Hannover Medical School, Hannover, Germany
Received 22 September 1998; received in revised form 6 January 1999; accepted 12 January 1999.
Corresponding author. Department of Cardiac and Vascular Surgery, Christian-Albrechts-Universität, Arnold-Heller-Str. 7, 24105 Kiel, Germany. Tel.: +49-431-597-4400; fax: +49-431-597-4402.
| Abstract |
|---|
|
|
|---|
50%, 2>50%) and distal (15
50%, 2>50%) to the anastomosis. Elevation of the LAD out of the vascular bed was an additional finding (n=12) in a few cases. Conclusions: The overall patency of MIDCAB-LAD-grafting appears to be equivalent to conventional IMA grafting to the LAD. Particular angiographic findings, however, may be directly associated to the applied surgical technique.
Key Words: Minimally invasive coronary surgery Left internal mammary artery bypass patency Beating heart surgery
| Introduction |
|---|
|
|
|---|
In regard to particular technical aspects like application of myocardial surface stabilization and use of perivascular snares or intravascular shunts, angiographic results have been discussed [5] [7]. Thereby, the accuracy and quality of the anastomosis has been repeatedly doubted. Moreover, changes of the native LAD and the entire IMA course have also raised concerns about the MIDCAB technique. Induced by these reports and our own experience of additional findings, which so far have not been consistently described, we performed a review of the original control angiographies in a group of surgeons and cardiologists, according to a standardized protocol in more than 200 cases.
| Materials and methods |
|---|
|
|
|---|
Respecting reported angiographic findings, an overall patency rate (LIMA, anastomosis, LAD) of 97.8% (227/232) became evident in 232 patients, but there were four cases with an unexpected attachment of diagonal branches instead of the intended LAD. Along with the description of particular angiographic findings in these reports, a review of the original control angiography material was committed by a group of surgeons and cardiologists. Thus, out of 232 control angiographies, 205 original films could be collected from different heart catheterization laboratories serving for a detailed analysis following a standardized protocol. Beyond only stenoses, particular angiographic findings were checked regarding the course and features of the LIMA like: course under tension, kinking, secondary fixation to the chest wall, dissection, intramural hematoma, intravascular thrombus, dominating side branches, competitive flow and spasm. In addition, all visible stenoses of the LIMA, the anastomosis and the native LAD (de novo stenoses different from preoperative findings) were separately noted and graded
50% or>50%.
Patients
The preoperative cardiac findings of the 205 patients (162 male, 43 female, 55.7±19 years, median 60 years), whose control angiographies were reviewed are listed in Table 1. Significant comorbidities were present in 119 cases. The reasons for accepting patients with multi vessel disease for only MIDCAB grafting were insignificant lesions or previous myocardial infarctions or not graftable vessels in non-LAD regions or primarily intended Hybrid procedures.
|
First, the technique of snaring for temporary occlusion of the LAD was changed using 4/0 polypropylene sutures and softer small silicone tubes to encircle the LAD only with one loop. The tension on these loops was very cautiously adjusted accepting some residual bleeding in many cases. Second, to get a better view of the vascular structures we relied on the aid of a blowing device (Medtronic DLP, Grand Rapids, MI). Third, for a better exposure of especially the more proximal segments of the LIMA, the ThoraLIFT® Retractor (Vascular Therapies, Norwalk, USA) was frequently used and allowed for an easier proximal dissection effecting increased IMA pedicle lengths. Otherwise mechanical retractor mounted stabilizers (CTS, Cupertino, CA) served for presentation of a motionless LAD region.
| Results |
|---|
|
|
|---|
Reviewing the postoperative control angiographies of 205 patients confirmed a global patency rate of 98.0% (201/205). However, in four cases the LIMA was unintendedly attached to diagonal branches ( Fig. 1 ) resulting in a sufficient retrograde flow to the LAD in three patients, whereas in one patient a subsequent percutaneous transluminal coronary angioplasty (PTCA) of the proximal LAD was required.
|
|
|
|
50% and>50% are summarized in Table 2. Overall 38 insignificant (
50%) stenoses were observed localized at the LIMA (n=5), anstomosis (n=4) and distal (n=15) or proximal (n=14) LAD. In contrast stenoses>50% were identified in 10 cases present at the LIMA (n=5), the anstomosis (n=1) and the distal (n=2) and proximal (n=2) LAD. Applying criteria as proposed by Fitzgibbons
[9] for LIMA evaluation in conventional bypass surgery, at least adequate function of widely patent grafts (
Fig. 6
) without stenoses>50% (including LIMA, anastomoses and distal LAD) was confirmed in 93.7%.
|
|
|
| Discussion |
|---|
|
|
|---|
Comparing our results obtained in a relatively large patient population over a 2-year-period with other big volume studies, the functional results appear comparable, but the proportion of control angiographies is evidently higher in our study. For example, Calafiore recently reported on 434 patients with MIDCAB grafting, but the graft patency rate of 93.7% could only be obtained from 271 patients [1]. Similar results were given by Subramanian [6]. A more detailed analysis of angiographic findings, however, is often missing and only patency rates are described. More detailed information is given by a few smaller studies with a high proportion of control angiographies. Thus, Alessandrini et al. [7] reported on de novo LAD stenoses close to the anastomosis, to probably be a result of the particular occluding technique. In the same sense were the results of Possati et al. [13]. Both studies raised major concerns about the quality of MIDCAB-revascularization, but with patient numbers of 35 [7] and 76 [13] the influence of the learning curve appears overrepresented.
The impact of LIMA stenoses and de novo LAD stenoses in early postoperative control angiographies may be less important for the long-term results, as Calafiore [1] reported a frequent resolution of such findings within 36 months, documented by serial angiographies. Even though we did not perform regular re-controls, none of our patients with such a stenosis became subsequently symptomatic. Only one patient with a transplant vasculopathy had a scheduled second control with an unchanged finding at 2 months.
Surgical critics of the MIDCAB-concept univocally state that with conventional techniques (sternotomy, heart-lung machine), regularly IMA patency rates between 97100% are obtainable as earlier published
[14]
[15]. The angiographic results, however, are usually not further differentiated regarding stenoses of the LIMA or the anastomoses or other irregularities. Referring to more recent results of LIMA-LAD grafting, the IMAGE trial
[16] seems appropriate assessing a global LIMA patency of 98.8% but also including 7.8% stenoses (>50%) of the LIMA. Consecutively, widely patent grafts without stenoses
50% were only seen in 91.0%
[16], which is quite similar to our MIDCAB results.
The evaluation of MIDCAB results in contrast to currently representative results of interventional approaches is obviously comparably difficult, as prospective trials investigating both techniques are also still missing. For a general survey, 62 German community hospitals formed the `Arbeitsgemeinschaft leitender kardiologischer Krankenhausärzte' (ALKK) (A. Vogt, personal communication), collected the data of 3816 elective PTCA/Stent procedures of the LAD in 1996 and reported LAD-occlusion rates between 1.22% (without stent) and 1.85% (with stent) and residual stenoses of
50% in 9.7% (without stent) and 8.3% (with stent), respectively. These, however, are postprocedural results which do not respect the expected incidence of restenoses between at least 1530% within 6 months. Moreover, these are already selected patients which are assumingly amenable to surgical techniques evenly, irrespective of patients who are only surgical candidates.
We conclude from our findings, that MIDCAB-results can be comparable with conventional LIMA-LAD grafting and superior to current interventional approaches in terms of angiographic results. To get a more precise information prospective, trials comparing MIDCAB with conventional bypass surgery and interventional procedures are absolutely necessary. Finally, to get a substantial feedback of one's own MIDCAB technique, control angiographies should be mandatory until adequate results are assessed.
| Acknowledgments |
|---|
| Footnotes |
|---|
| Appendix A. Conference discussion |
|---|
|
|
|---|
The second most important step is the LIMA graft harvesting, I think inadequate graft harvesting is one of the important factors which give rise to anastomotic failure and short graft length, the fixation problem you talked about.
Thirdly, clinical follow-up of 205 patients with LIMA LAD have been done since stabilization, and clinical event rate have yielded a low clinical event rate and target vessel revascularization rate. Which is better than the best stent restenosis rate, 15%.
Dr Cremer: So far, we have the same opinion and we changed our technique a little bit and are very cautious with the application of snares. As well, we changed the preparation of the IMA. We go a little bit further up now, and we have the same impression that the distal part especially is very sensitive to vascular wall dissection. Thus, we are very cautious with the preparation here.
Dr A. Wahba (Regensburg, Germany): I think that the finding of distal stenosis of the coronary artery from using snares is quite worrying. In our experience after we started using a blower, very often the distal snare became unnecessary. Now we usually start without applying a distal snare and this should solve the problem of distal stenosis.
Dr Cremer: That is also our impression, and we use now very low tension on the snares and wait when incising the vessel, whether it is bleeding or not. In cases of persisting bleeding, the support of a blowing device allows an adequate visualization of the vascular structures. Since that, we don't see this problem of snares. So it is an initial experience with the start of the program.
Dr F. Benetti (Santa Fe, Argentina): Only one comment. This is a good operation, it is a difficult operation, you could obtain good results, but for the moment we move to do this operation for what we would call the safer approach, instead of going through the mini thoracotomy, and we think that this approach is easier in terms of harvesting the LIMA and to perform the anastomosis, and it is also less painful initially, and is not also less painful, but you can build the anastomosis more easily and most of the surgeons are used to doing this approach. So we prefer instead, the left anterior thoracotomy at this moment, to go for what we call the safer approach or lower inferior approach.
Dr Cremer: With the problem of pain, there is no absolute solution, so you can't say patients with a mini-thoracotomy on the left side have less pain than with a sternotomy, but I think over some days the issue of pain can be neglected in the patient's course.
Dr R. Dion (Brussels, Belgium): You mentioned that 87 patients had a two- or three-vessel disease. Could you explain how you can think to treat two- or three-vessel disease by means of a single mammary artery graft on the LAD?
Dr Cremer: I've waited for this question. Part of them received a hybrid procedure and another part of them had a previous infarction with probably no viable tissue or there were also some cases with minor stenosis, less than 50%, and they were referred for a MIDCAB procedure. I think it makes sense.
Mr W. Dimitri (Coventry, UK): I must congratulate you on two things, one is the excellent results and two, the number of angiograms you have done. You have almost achieved a virtual total angiographic study. Most people do not have this facility and in fact are unable to follow these patients angiographically. I am not sure whether you have done intraoperative flow studies looking at wave forms and so on.
Do you think by looking simply at the intraoperative flow patterns of the mammary you can predict what the graft is going to do, what the mammary is going to do 8 days later, which is still an early investigation?
Dr Cremer: We didn't do any flow study, and having the herein presented particular findings in mind, I doubt very much that a flow study or a Doppler study alone would give sufficient information about the graft.
Dr D. Adams (Boston, MA, USA): What did you do with the 7% of patients that had greater than 50% narrowing distally? What did you do with others with poor angiographic results? Were they reoperated on?
Dr Cremer: No, none of the patients had a reoperation. Three of the patients with occluded grafts had an interventional procedure and for the other patients, we waited while they became symptomatic or not. They had functional studies, like stress ECG, but they were not positive until now.
Dr Adams: Some of your patients had single-vessel disease, and if they were in that group, that wouldn't make sense. If they had a single vessel CABG and they had a greater than 50% narrowing, they should have a positive functional study, you would think.
The other question is related to the need for angiography. Are you currently recommending angiography for MIDCABs, and are you recommending it for all CABGs if you assume that all grafts have an 8% failure rate?
Dr Cremer: We would just recommend it for MIDCABs because this is new technology, and in many groups there are still learning curves present.
Dr Adams: The point is, if you think that both conventional and MIDCABs have an 8% graft failure rate, should we be performing an angiogram on every patient, whether they have a MIDCAB or a full sternotomy? I don't think we should accept an 8% graft failure rate.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Fraund, G. Herrmann, A. Witzke, J. Hedderich, G. Lutter, M. Brandt, A. Boning, and J. Cremer Midterm Follow-Up After Minimally Invasive Direct Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention Techniques Ann. Thorac. Surg., April 1, 2005; 79(4): 1225 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Weigang, J. Royl, A. Dencker, J. Schoellhorn, A. van de Loo, and F. Beyersdorf Results after MIDCAB and OPCAB surgeries: problems and consequences of incomplete angiographic follow-up in the mid-term course Interactive CardioVascular and Thoracic Surgery, June 1, 2004; 3(2): 302 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Alhabash, A. Tirouvanziam, J.C. Roussel, and D. Duveau Early and 1 year angiographic evaluation of graft patency in off-pump coronary bypass surgery via sternotomy Interactive CardioVascular and Thoracic Surgery, June 1, 2003; 2(2): 149 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fraund, H. Behnke, A. Boening, and J. Cremer Immediate postoperative extubation after minimally invasive direct coronary artery surgery (MIDCAB) Interactive CardioVascular and Thoracic Surgery, September 1, 2002; 1(1): 41 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Falk Manual control and tracking--a human factor analysis relevant for beating heart surgery Ann. Thorac. Surg., August 1, 2002; 74(2): 624 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. Mohr, V. Falk, A. Diegeler, T. Walther, J. F. Gummert, J. Bucerius, S. Jacobs, and R. Autschbach Computer-enhanced ""robotic"" cardiac surgery: Experience in 148 patients J. Thorac. Cardiovasc. Surg., May 1, 2001; 121(5): 842 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. O. Vetter, R. Driever, H. Mertens, U. Kempkes, and B. M. Cramer Contrast-enhanced magnetic resonance angiography of mammary artery grafts after minimally invasive coronary bypass surgery Ann. Thorac. Surg., April 1, 2001; 71(4): 1229 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lichtenberg, U. Klima, A. Ruhparwar, A. Haverich, P. B. Berger, H. V. Schaff, E. L. Alderman, and A. Nadel Graft Patency Rate and Clinical Outcome After Coronary Artery Bypass Surgery Response Circulation, January 16, 2001; 103 (2): e10 - e10. [Full Text] [PDF] |
||||
![]() |
A. Diegeler, N. Spyrantis, M. Matin, V. Falk, R. Hambrecht, R. Autschbach, F. W. Mohr, and G. Schuler The revival of surgical treatment for isolated proximal high grade LAD lesions by minimally invasive coronary artery bypass grafting Eur. J. Cardiothorac. Surg., May 1, 2000; 17(5): 501 - 504. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |